.jpg)
Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
Chorus of Critics Greets New Psychiatric Manual Release
(NBC News Vitals) May 16, 2013 - The fifth edition of the American Psychiatric Association's manual of mental disorders is finally out, offering the latest revision in nearly 20 years of the diagnostic bible used by individuals and agencies, insurers, schools and government bodies to navigate the mental health landscape.
read article 
ThromboGenics Reports Jetrea Sales as Drug Fails Mid-Stage Study
(Bloomberg) May 16, 2013 - ThromboGenics NV reported sales of its eye drug that reached $10 million after four months on the U.S. market while saying the treatment failed in a study targeting an expanded use.
read article
Johnson & Johnson to Discontinue Metal-on-Metal Hip Products
(Morningstar/Dow Jones Newswires) May 16, 2013 - Johnson & Johnson said it will discontinue its line of metal-on-metal replacement hips, exiting a product category that became the subject of regulatory scrutiny and thousands of customer lawsuits.
read article
New Jersey Hospital Is the Costliest in the Nation
(New York Times) May 16, 2013 - The most expensive hospital in America is not set amid the swaying palm trees of Beverly Hills or the luxury townhouses of New York's Upper East Side.
read article
Pills Tracked From Doctor to Patient to Aid Drug Marketing
(New York Times) May 16, 2013 - Vast databases of patient and doctor information being used by drug makers let them know which medications physicians are prescribing and how they compare to colleagues.
read article
Halozyme Rises on Pancreatic Cancer Drug Study
(Yahoo! News/Associated Press) May 16, 2013 - Shares of Halozyme Therapeutics Inc. climbed Thursday after the company reported clinical trial data for an experimental cancer drug.
read article
The American Cancer Society Celebrates 100 Years
(Knoxville News Sentinel) May 16, 2013 - The organization that coined the tagline "The official sponsor of birthdays" is celebrating a monumental one of its own on May 22.
read article
Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
(The Street) May 17, 2013 - I'm not optimistic about Vical or its skin cancer immunotherapy Allovectin.
read article
Bellicum in Trials with Cancer Vaccine, Cell-Suicide Switches
(Xconomy Texas) May 16, 2013 - Less than a decade after being hatched out of a Texas university, Houston-based Bellicum Pharmaceuticals is in the midst of clinical trials on two innovative cancer therapies that, if successful, could result in new ways of attacking and killing off harmful cells.
read article
Celsion's ThermoDox HEAT Study Findings Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO)
(Yahoo! Finance) May 17, 2013 - Celsion Corporation announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, 2013 WCIO Program Chairman and the Director of the Division of Diagnostic Imaging and Intervention at Pisa University School of Medicine in Italy and Lead European Principal Investigator for the HEAT Study and Professor Ronnie T.P. Poon, MD, MS, PhD, FRCS(Edin), FACS, Professor of Surgery at the University of Hong Kong and Lead Asia Pacific Principal Investigator for the HEAT Study conducted separate scientific discussions reviewing the clinical trial results from the Company's Phase III HEAT Study including new emerging findings from the HEAT Study post-hoc analysis at the 9th Annual Meeting of the World Conference on Interventional Oncology, which is being held on May 16 to 20, 2013 in New York City.
read article
ApoCell Announces Delivery of First Prototypes of ApoStreamTM Circulating Tumor Cell (CTC) Isolation Technology to National Cancer Institute
(MarketWatch) May 15, 2013 - ApoCell, Inc. announced that the first prototypes of its ApoStreamTM circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI).
read article
Transgenomic Announces Global Availability of CRC RAScan Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
(Reuters) May 16, 2013 - Transgenomic, Inc. today announced the global, commercial availability of CRC RAScan, a new mutation detection test to screen patients with metastatic colorectal cancer (mCRC) for RAS mutations (KRAS and NRAS).
read article
Doctors Should Discuss Financial Concerns of Cancer Patients
(DukeHealth.org) May 16, 2013 - Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.
read press release
First Prospective Trial Shows Molecular Profiling Timely for Tailoring Therapy
(Georgetown University Medical Center) May 15, 2013 - A clinical trial has shown that patients, and their physicians, are eager to jump into next-era cancer care — analysis of an individual's tumor to find and target genetic mutations that drive the cancer.
read press release
Physical & Emotional Impairments Common, Often Untreated in People with Cancer
(ACS) May 17, 2013 - A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system.
read press release
Cancer Survivors Battle with the Blues
(Springer) May 16, 2013 - Depressed cancer survivors are twice as likely to die prematurely than those who do not suffer from depression, irrespective of the cancer site. That's according to a new study, by Floortje Mols and colleagues, from Tilburg University in The Netherlands.
read press release
Research to End Asbestos-Related Cancer
(Flinders University [Adelaide, South Australia]) May 16, 2013 - Scientists from Flinders University are trying to develop a new treatment for a highly aggressive, asbestos-related lung cancer that is set to become more prevalent in the future.
read press release
Study Suggests Cuataneous Squamous Cell Carcinoma Carries Risk of Metastasis and Death
(JAMA Network) May 15, 2013 - A study by Chrysalyne D. Schmults, M.D., M.S.C.E., of Brigham and Women's Hospital, Boston, and colleagues suggests cutaneous squamous cell carcinoma (CSCC) carries a low but significant risk of metastasis and death.
read press release
Research Identifies Potential Drug Targets for Incurable Cancer of Small Bowel
(Mayo Clinic) May 15, 2013 - Researchers at Mayo Clinic have completed the world's first whole exome sequence of small intestine neuroendocrine tumors, also known to patients and physicians as carcinoids, the most common cancer of the small bowel and one that responds poorly to chemotherapy.
read press release
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
(Sanofi) May 17, 2013 - Sanofi announced today that the pivotal study, JAKARTA, examining the selective JAK2 inhibitor SAR302503 for myelofibrosis (MF), met its primary endpoint in both dose groups.
read corporate press release
Gene-Testing Dispute Focuses on How Much a Patient Should Know
(Bloomberg) May 16, 2013 - Should patients undergoing broad DNA testing for a specific ailment be told of unexpected findings that signal risk of cancer or other serious diseases, even if they don't request the information?
read article
A Dilemma in the Search for Breast Cancer
(Wall Street Journal) May 16, 2013 - Doctors are divided about how best to scan "dense" breasts. A look at the options.
read article (paid subscription required)
Oregon Scientists Get Stem Cells From Cloned Human Embryos
(Washington Post) May 15, 2013 - A research team in Oregon has produced embryonic stem cells from cloned human embryos.
read article (free registration required)
Drug Firms Stalk Actavis Deal
(Wall Street Journal) May 16, 2013 - A heated takeover battle has erupted around generic-drug company Actavis Inc. as industry players seek to shore themselves up amid increasing competition and fewer new knock-off-drug opportunities.
read article (paid subscription required)
J&J Wins Expanded Approval of Simponi for Bowel Disease
(Bloomberg) May 15, 2013 - Johnson & Johnson won U.S. approval to use its rheumatoid arthritis drug Simponi to treat patients suffering from a moderate to severe inflammatory bowel disease.
read article